Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Fresenius completa la adquisición de mAbxience, creando una plataforma más sólida para la futura expansión de su cartera de productosCompanies: Fresenius SE & Co. KGaAmAbxience ha anunciado hoy que Fresenius SE & Co. KGaA ha adquirido el 45% restante de mAbxience a Insud Pharma, consolidando así la exitosa...
- mAbxienceFresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansionCompanies: Fresenius SE & Co. KGaAThe transaction builds on the successful partnership between Fresenius and mAbxience established in 2022. Full ownership creates a stronger platform to enhance quality and supply resilience, while supporting future innovation and broader patient access to high-quality biosimilars....
- Fresenius Medical Care Holdings, Inc.Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market LeadershipCompanies: Fresenius SE & Co. KGaARefinements support the Company's China go-to-market and commercial strategy in an important and growing market Strategy focuses on localized portfolio and innovation in China Portfolio decisions expected to result in related one-time costs in Q3 2026 treated as a special item BAD...